NANTERRE
RETROUVEZ GRATUITEMENTLe résultat des européennes à Nanterre ainsi que le résultat des européennes dans les Hauts-de-Seine.
Dr. Alain L. Servin, PhD
Retired Research Director at Inserm
Expert Consultant
UMR CNRS 8076 BioCis
Faculty of Pharmacy,University Paris-Sud
92296. Châtenay-Malabry
France
alain.servin@u-psud.fr
http://cvscience.aviesan.fr/cv/827/alain-l-servin
https://www.researchgate.net/profile/Alain_Servin
Alain L. Servin received his Doctorat d’Université (University Paris-Sud) in 1973 and Doctorat d’Etat es Sciences (University Paris VI) in 1987. In 1980 he joined the French National Institute of Health and Medical Research (Inserm), working on Biophysic and Cellular Pharmacology (Inserm Institute Saint Antoine Hospital, Paris, and Unit 178 Paul Brousse Hospital, Villejuif). He was research director and head of research teams Inserm and University Paris-Sud (CJF 94.07, Units 510 and 756, Federative Research Institute 75) between 1990 and 2010 at the Faculty of Pharmacy Châtenay-Malabry. He mentored 15 doctoral and postdoctoral fellows who continued their careers in academia, Inserm, CNRS, Anses, and industry.
130 international publications et 9 US and European patents
Date of Birth : 1946, December 11. Paris 14, France
Degrees and Academic titles
1973 - Doctorat en Sciences Naturelles. University Paris-Sud
1987 - Doctorat d’Etat es Sciences. University Pierre et Marie Curie Paris 6 (PhD)
1979 - Capacity of Law. University Nanterre-Paris X
1980 - DESS Pharmaceutical Law. University Paris-Sud
Distinctions and Prizes
French Academy of Medicine (Prix Clarens 1975
French Academy of Medicine (Prix de Pharmacie 1988)
Officier de l’Ordre National du Mérite, 2008
Head of Research Teams
Head of CJF 94.07 Inserm « Physiopathologie des Microorganismes Entérovirulents » (1994-1998)
Head of Research Unit 510 Inserm "Pathogènes et Fonctions des Cellules Epithéliales Polarisées” (1999-2005)
Head of Institut de Signalisation et d’Innovation Thérapeutique ‘IFR75” (2002-2005)
Head of team « Signalisation et Relation Hôte-Pathogènes ». Research Unit Inserm 756. Faculté de Pharmacie Châtenay-Malabry. Université Paris-Sud 11. (2005-2011)
Main recent activities
Scientific Council Inserm (1995-1999 and 2003-2007)
Specialized Scientific Committees Inserm n° 1 (Microbiology, Genetic, Pharmacology) (1983-1987) and n° 2 (Gastroenterology, Nephrology) (1991-1994)
Scientific Committee Inserm (Infectious and Parasitic Diseases in France and Worldwide) (1992-1995)
Committee of Human Nutrition. French National Agency Afssa « Sécurité Sanitaire des Aliments » and French Agency for Food, Environment and Occupational Health and Safety (Anses) (2006-2016)
Expert Scientific Committees: Food and Agriculture Organization of the United Nations (FAO/WHO), Canadian Institutes of Health; CONICY; ECOS; Agency for Science, Welcome Trust; European Community; Israel Science Foundation, United States-Israel Binational Science Foundation; International Foundation for Science; Broad Foundation, French National Research Evaluation Committee (AERES)…..
The Servin’s laboratories in the emerging field called Cellular Microbiology, has focused his research interest on host-microbial pathogen interactions by combining cell biology with microbiology. Research conducted by Alain L. Servin and colleagues for over 20 years focused on understanding the cellular and molecular mechanisms of pathogenesis of enterovirulent or uropathogenic Escherichia coli expressing Afa/Dr adhesins (diffusely-adhering E. coli - DAEC) and rotavirus. A basic research adds a component applied research with the aim, the development of biotherapeutic agents through the use of probiotic strains of lactobacilli isolated from human vaginal and intestinal microbiota to treat bacterial and viral diarrhea and vaginal infections.
.
Mes compétences :
Pathogénèse microbienne intestinale
Probiotiques
